Blood & Tissue Collection Centers

Guidance

• FDA – Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components (August 26, 2016)[PDF – 17 pages]
• FDA – Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products[PDF – 10 pages]

Additional Resources

• Zika Virus Response Updates from FDA
• Cost Projections for Implementation of Safety Interventions to Prevent Transfusion-Transmitted Zika Virus Infection in the United States
• Investigation Toolkit: Transfusion-transmitted Infections (TTI)
• Investigation Toolkit:  Transplant-Transmitted Infection
• MMWR: Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection – Puerto Rico, 2016
• AABB – American Association of Blood Banks
• Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April—August 2016 (EID)

CDC is working with our partners to learn more about Zika and blood/tissue safety

• AABB – American Association of Blood Banks
• FDA – US Food and Drug Administration
• State and territorial health departments
• Blood collection centers
• HCT/P collection centers